Cargando…
A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying bla(NDM-4), tet(X), and tmexCD3-toprJ3 Confers Resistance to Carbapenem and Tigecycline
Tigecycline is a last-resort antimicrobial against carbapenemase-producing Enterobacterales (CPE). However, mobile tigecycline resistance genes, tet(X) and tmexCD-toprJ, have emerged in China and have spread possibly worldwide. Tet(X) family proteins function as tigecycline-inactivating enzymes, and...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386453/ https://www.ncbi.nlm.nih.gov/pubmed/34346701 http://dx.doi.org/10.1128/mSphere.00592-21 |
_version_ | 1783742265401802752 |
---|---|
author | Hirabayashi, Aki Dao, Trung Duc Takemura, Taichiro Hasebe, Futoshi Trang, Le Thi Thanh, Nguyen Ha Tran, Hoang Huy Shibayama, Keigo Kasuga, Ikuro Suzuki, Masato |
author_facet | Hirabayashi, Aki Dao, Trung Duc Takemura, Taichiro Hasebe, Futoshi Trang, Le Thi Thanh, Nguyen Ha Tran, Hoang Huy Shibayama, Keigo Kasuga, Ikuro Suzuki, Masato |
author_sort | Hirabayashi, Aki |
collection | PubMed |
description | Tigecycline is a last-resort antimicrobial against carbapenemase-producing Enterobacterales (CPE). However, mobile tigecycline resistance genes, tet(X) and tmexCD-toprJ, have emerged in China and have spread possibly worldwide. Tet(X) family proteins function as tigecycline-inactivating enzymes, and TMexCD-TOprJ complexes function as efflux pumps for tigecycline. Here, to the best of our knowledge we report a CPE isolate harboring both emerging tigecycline resistance factors for the first time. A carbapenem- and tigecycline-resistant Klebsiella aerogenes strain, NUITM-VK5, was isolated from an urban drainage in Vietnam in 2021, and a plasmid, pNUITM-VK5_mdr, cocarrying tet(X) and tmexCD3-toprJ3 along with the carbapenemase gene bla(NDM-4) was identified in NUITM-VK5. pNUITM-VK5_mdr was transferred to Escherichia coli by conjugation and simultaneously conferred high-level resistance against multiple antimicrobials, including carbapenems and tigecycline. An efflux pump inhibitor reduced TMexCD3-TOprJ3-mediated tigecycline resistance, suggesting that both tigecycline resistance factors independently and additively contribute to the high-level resistance. The plasmid had the IncX3 and IncC replicons and was estimated to be a hybrid of plasmids with different backbones. Unlike IncX3 plasmids, IncC plasmids are stably maintained in an extremely broad range of bacterial hosts in humans, animals, and the environment. Thus, the future global spread of multidrug resistance plasmids such as pNUITM-VK5_mdr poses a public health crisis. IMPORTANCE Tigecycline is important as a last-resort antimicrobial and effective against antimicrobial-resistant bacteria, such as carbapenem-producing Enterobacterales (CPE), whose infections are difficult to treat with antimicrobials. Since 2019, mobile tigecycline resistance genes, tet(X) and tmexCD-toprJ, and their variants have been reported mainly from China, and it has become important to understand their epidemiological situation and detailed genetic mechanisms. In this study, we identified a bacterial isolate coharboring tet(X) and tmexCD-toprJ on the same plasmid. A Klebsiella aerogenes isolate in Vietnam carried both these tigecycline resistance genes on a transferable plasmid leading to high-level resistance to multiple clinically important antimicrobials, including carbapenem and tigecycline, and could actually transfer the plasmid to other bacteria. The spread of such a multidrug resistance plasmid among bacterial pathogens should be of great concern because there are few antimicrobials to combat bacteria that have acquired the plasmid. |
format | Online Article Text |
id | pubmed-8386453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-83864532021-09-09 A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying bla(NDM-4), tet(X), and tmexCD3-toprJ3 Confers Resistance to Carbapenem and Tigecycline Hirabayashi, Aki Dao, Trung Duc Takemura, Taichiro Hasebe, Futoshi Trang, Le Thi Thanh, Nguyen Ha Tran, Hoang Huy Shibayama, Keigo Kasuga, Ikuro Suzuki, Masato mSphere Research Article Tigecycline is a last-resort antimicrobial against carbapenemase-producing Enterobacterales (CPE). However, mobile tigecycline resistance genes, tet(X) and tmexCD-toprJ, have emerged in China and have spread possibly worldwide. Tet(X) family proteins function as tigecycline-inactivating enzymes, and TMexCD-TOprJ complexes function as efflux pumps for tigecycline. Here, to the best of our knowledge we report a CPE isolate harboring both emerging tigecycline resistance factors for the first time. A carbapenem- and tigecycline-resistant Klebsiella aerogenes strain, NUITM-VK5, was isolated from an urban drainage in Vietnam in 2021, and a plasmid, pNUITM-VK5_mdr, cocarrying tet(X) and tmexCD3-toprJ3 along with the carbapenemase gene bla(NDM-4) was identified in NUITM-VK5. pNUITM-VK5_mdr was transferred to Escherichia coli by conjugation and simultaneously conferred high-level resistance against multiple antimicrobials, including carbapenems and tigecycline. An efflux pump inhibitor reduced TMexCD3-TOprJ3-mediated tigecycline resistance, suggesting that both tigecycline resistance factors independently and additively contribute to the high-level resistance. The plasmid had the IncX3 and IncC replicons and was estimated to be a hybrid of plasmids with different backbones. Unlike IncX3 plasmids, IncC plasmids are stably maintained in an extremely broad range of bacterial hosts in humans, animals, and the environment. Thus, the future global spread of multidrug resistance plasmids such as pNUITM-VK5_mdr poses a public health crisis. IMPORTANCE Tigecycline is important as a last-resort antimicrobial and effective against antimicrobial-resistant bacteria, such as carbapenem-producing Enterobacterales (CPE), whose infections are difficult to treat with antimicrobials. Since 2019, mobile tigecycline resistance genes, tet(X) and tmexCD-toprJ, and their variants have been reported mainly from China, and it has become important to understand their epidemiological situation and detailed genetic mechanisms. In this study, we identified a bacterial isolate coharboring tet(X) and tmexCD-toprJ on the same plasmid. A Klebsiella aerogenes isolate in Vietnam carried both these tigecycline resistance genes on a transferable plasmid leading to high-level resistance to multiple clinically important antimicrobials, including carbapenem and tigecycline, and could actually transfer the plasmid to other bacteria. The spread of such a multidrug resistance plasmid among bacterial pathogens should be of great concern because there are few antimicrobials to combat bacteria that have acquired the plasmid. American Society for Microbiology 2021-08-04 /pmc/articles/PMC8386453/ /pubmed/34346701 http://dx.doi.org/10.1128/mSphere.00592-21 Text en Copyright © 2021 Hirabayashi et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Hirabayashi, Aki Dao, Trung Duc Takemura, Taichiro Hasebe, Futoshi Trang, Le Thi Thanh, Nguyen Ha Tran, Hoang Huy Shibayama, Keigo Kasuga, Ikuro Suzuki, Masato A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying bla(NDM-4), tet(X), and tmexCD3-toprJ3 Confers Resistance to Carbapenem and Tigecycline |
title | A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying bla(NDM-4), tet(X), and tmexCD3-toprJ3 Confers Resistance to Carbapenem and Tigecycline |
title_full | A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying bla(NDM-4), tet(X), and tmexCD3-toprJ3 Confers Resistance to Carbapenem and Tigecycline |
title_fullStr | A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying bla(NDM-4), tet(X), and tmexCD3-toprJ3 Confers Resistance to Carbapenem and Tigecycline |
title_full_unstemmed | A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying bla(NDM-4), tet(X), and tmexCD3-toprJ3 Confers Resistance to Carbapenem and Tigecycline |
title_short | A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying bla(NDM-4), tet(X), and tmexCD3-toprJ3 Confers Resistance to Carbapenem and Tigecycline |
title_sort | transferable incc-incx3 hybrid plasmid cocarrying bla(ndm-4), tet(x), and tmexcd3-toprj3 confers resistance to carbapenem and tigecycline |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386453/ https://www.ncbi.nlm.nih.gov/pubmed/34346701 http://dx.doi.org/10.1128/mSphere.00592-21 |
work_keys_str_mv | AT hirabayashiaki atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT daotrungduc atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT takemurataichiro atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT hasebefutoshi atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT tranglethi atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT thanhnguyenha atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT tranhoanghuy atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT shibayamakeigo atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT kasugaikuro atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT suzukimasato atransferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT hirabayashiaki transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT daotrungduc transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT takemurataichiro transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT hasebefutoshi transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT tranglethi transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT thanhnguyenha transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT tranhoanghuy transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT shibayamakeigo transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT kasugaikuro transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline AT suzukimasato transferableinccincx3hybridplasmidcocarryingblandm4tetxandtmexcd3toprj3confersresistancetocarbapenemandtigecycline |